J Hematol Oncol.: “GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways.”

“GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways.” Guerenne L, Beurlet S, Said M, Gorombei P, Le Pogam C, Guidez F, de la Grange P, Omidvar N, Vanneaux V, Mills K, Mufti GJ, Sarda-Mantel L, Noguera ME, Pla M, Read more…

In Hum Mol Genet.: “Molecular analyses of juvenile granulosa cell tumors bearing AKT1 mutations provide insights into tumor biology and therapeutic leads”

“Molecular analyses of juvenile granulosa cell tumors bearing AKT1 mutations provide insights into tumor biology and therapeutic leads.” Auguste A, Bessière L, Todeschini AL, Caburet S, Sarnacki S, Prat J, D’Angelo E, de la Grange P, Ariste O, Lemoine F, Legois B, Sultan C, Zider A, Galmiche L, Kalfa N, Read more…

In Oncotarget: Expression of the potential therapeutic target CXXC5 in primary acute myeloid leukemia cells

“Expression of the potential therapeutic target CXXC5 in primary acute myeloid leukemia cells – high expression is associated with adverse prognosis as well as altered intracellular signaling and transcriptional regulation.” Bruserud Ø, Reikvam H, Fredly H, Skavland J, Hagen KM, van Hoang TT, Brenner AK, Kadi A, Astori A, Gjertsen Read more…